VICO — Vicore Pharma Holding AB Share News
0.000.00%
- SEK2.73bn
- SEK1.83bn
- SEK3.82m
Advisory: Multiple dated alerts withdrawn
Brief: Vicore Pharma: Positive Top Line Data From ATTRACT Clinical Study In Patients With Covid-19
Brief: Vicore Pharma Holding AB - July-Sept Operating Loss Was -34.4 Msek
Brief: Vicore Buys Novel AT2R Agonists And Decides On Issue In Kind
Brief: Vicore Pharma Announces Effects Of VP01 On IPF Patient Tissue
Brief: Vicore Pharma Holding Q2 Operating Loss Widens To SEK 27.5 Mln
Brief: Vicore Pharma Restarts Mechanistic Study With Vp01 In Systemic Sclerosis
Brief: Vicore Pharma Doses First COVID-19 Patient In ATTRACT Study
Brief: Vicore Pharma Holding Carries Out Directed New Share Issue
Brief: Vicore Pharma Says Completed Directed Share Issue Of SEK 185 Mln
Brief: Vicore Pharma Intends To Carry Out A Directed Share Issue
Brief: Vicore Pharma: Drug Candidate VP01 Demonstrates Potential
Brief: Vicore Pharma Gets Grant From LifeArc For VP01 COVID-19 Clinical Study
Brief: Vicore Q1 Operating Loss Widens To SEK 28.8 Million
Brief: Vicore Pharma Gets Regulatory Approval To Start Phase II Clinical Trial With VP01
Brief: Vicore Pharma Says No Coronavirus Impact On Submission
Brief: Vicore Pharma Holding Q4 Operating Loss Widens To SEK 30.2 Million
Brief: Vicore Pharma To Carry Out Directed Issue
Brief: Vicore Pharma Completes Directed Share Issue Of About SEK 125 Mln